Create a fund in your name to generate new technological advances and ensure long-term employment for a panel of competent researchers on the campus
To ensure high-quality research, the Medalis research centre wishes to develop a donor fund allowing: long-term employment of a group of research engineers and technicians, to ensure a “memory” for our mission, the team will be enriched through experience thanks to the multiple projects mentored
consolidation of research infrastructures and investment in state-of-the-art equipment
Why donate to a research centre?
Bring drug production back to Europe
Supporting drug development in Europe is a crucial strategic challenge, as revealed by the recent health crisis. Help a French research centre to develop tomorrow’s therapies.
An essential societal commitment for numerous patients
Supporting the search for new drugs is an inestimable support for health for everyone, an authentic CSR approach in the service of future novel therapeutic solutions for patients.
Develop a high-level scientific network
By supporting the Medalis research centre, you become an official funder of the institute. In this capacity, you can develop strong links with researchers from internationally-renowned laboratories.
Optimise your donation
The IMS is associated with the Foundation for Chemistry Research so that all donations from companies fiscally resident in France are eligible for a 60% rebate on companies’ tax (Impôt sur les Sociétés) (within the limit of 0.5% of turnover).
Support a new generation of students through the DDD challenge
The Strasbourg Drug Discovery and Development Institute is a renowned entity training future managers for drug discovery and development. Its Euridis school provides the opportunity for brilliant international students to reveal their innovation potential, and mentors them in an entrepreneurial project right up to creation of their start-up. Every year, Medalis research teams work in close collaboration with clinicians to launch a challenge open to Euridis students based on an identified medical need: the DDD challenge.
Consisting of interdisciplinary pairs of students, the winners will be awarded PhD funding along with an operating budget to support the launch of a project with a high potential for transfer.
This challenge allows the Strasbourg Institute for Drug Development to attract very high-achieving international talents, and to train these brilliant students up to PhD level on drugs-market-oriented research themes.
Identify future collaborators
As a partner company of Euridis and the DDD challenge, you will come into contact with the tomorrow’s scientific managers, and researchers trained in bringing novel therapeutic solutions to market.
Optimise your donation
The IMS is associated with the Foundation for Chemistry Research so that all donations from companies fiscally resident in France are eligible for a 60% rebate on companies’ tax (Impôt sur les Sociétés) (within the limit of 0.5% of turnover).
Launch promising start-ups by contributing to their equity capital
The IMS ensures mentoring for its start-ups through its entrepreneurial maturation centre Inedis.
At this stage, a start-up needs equity capital to transform its technological project into a business model.
Your support is essential to the companies to continue the pre-clinical development of their therapeutic innovations.
Why become a donor contributing to our start-ups ?
Bring drug production back to Europe
Supporting drug development in Europe is a crucial strategic challenge, as revealed by the recent health crisis. Help French start-ups to develop tomorrow’s therapies.
An essential societal commitment for numerous patients
The institute selects the most promising drug-related start-ups. Contributing to the development of start-ups through a donation to their equity capital is an inestimable support towards achieving market access for these new therapies and making novel therapeutic solutions available to patients.
Develop a high-level scientific network
By supporting our start-ups, you become an official contributor to emerging pharmaceutical companies in the region. In this capacity, you can develop strong links with researchers from internationally-renowned laboratories.
Optimise your donation
The IMS is associated with the Foundation for Chemistry Research so that all donations from companies fiscally resident in France are eligible for a 60% rebate on companies’ tax (Impôt sur les Sociétés) (within the limit of 0.5% of turnover).
Major donors benefit from an acknowledgement programme
Communication on donations by the Strasbourg Drug Development Institute, the University of Strasbourg and the Foundation for Chemistry Research through their communication channels (social networks and web sites)
Tailored returns depending on your commitment: naming of funds or PhD grants after the donor, consultative participation in the scientific advisory board of Medalis or the Board of Inedis, etc.
Recognition programme at the University of Strasbourg